Stocks to sell

Robinhood Markets (NASDAQ:HOOD) got off to a rocky start following its recent initial public offering. HOOD stock closed its first trading day down more than 8%. Source: OpturaDesign / Shutterstock.com In the days that followed, Robinhood has skyrocketed to more than double its $38 IPO price. There’s no question Robinhood has been a tremendous success
0 Comments
Ashford Hospitality Trust (NYSE:AHT) claims to be “well-positioned to capitalize on the lodging recovery” its investor presentation. But judging by the price action of AHT stock, the shareholders have definitely not been capitalizing as they’ve struggled to get back to break even. Source: Shutterstock Regardless, the company claims to have a “clear path forward to capitalize
0 Comments
As longtime readers know, I’m a huge electric vehicle (EV) stock bull. I’m 100% confident that electric vehicles will entirely replace gas-powered by cars by 2040, thanks to improving EV technology, falling battery costs, shifting consumer demand to eco-friendly products, and increasing supply of EVs. At this point, the EV Revolution is inevitable, and EV
0 Comments
Bionano (NASDAQ:BNGO) is a small life sciences company. Biotech companies use Bionano’s Saphyr system for researching DNA and to diagnose illnesses caused by genetics. Up until recently, Bionano has had difficulty achieving widespread market adoption for Saphyr. However, BNGO stock has gone on a wild ride over the past year as traders gravitated to Bionano’s
0 Comments
In a matter of weeks, DiDi Global (NYSE:DIDI) stock has gone from a hot IPO to an undeniable disaster. Soon after its debut on the U.S. stock market at an initial price of $14 per share, the China-based ride-hailing company was hit hard by the  Chinese government’s decision to investigate and penalize it. The shares
0 Comments
A decade ago, after returning to finance from 30 years covering computer technology, I got into an argument over a company called Dendreon. You’ll see why this lingering thoughts connects me to BIIB stock below. Source: PictureDesignSwiss / Shutterstock.com Dendreon had launched a treatment for prostate cancer called Provenge. It is an immunotherapy, tied to
0 Comments
GameStop (NYSE:GME) stock has been one of 2021’s most incredible investing stories. The initial short squeeze was incredible to watch. Few market analysts could have ever imagined that a struggling mall retailer like GameStop could see its shares surge thousands of percent. Source: rblfmr / Shutterstock.com That surge, in turn, saved the company. GameStop raised
0 Comments
Other than a short-lived rally in June fueled by Reddit users, ContextLogic (NASDAQ:WISH) stock is on a permanent trajectory downward. Source: sdx15 / Shutterstock.com WISH stock peaked at $32.85, shortly after its initial public offering earlier this year. The company’s unfavorable valuations, mixed first-quarter results, and poor sales forecast continue to weigh on its share
0 Comments